Core Viewpoint - Social Commerce Partners Corporation has announced the pricing of its initial public offering (IPO) of 10,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of a redeemable warrant [1] Group 1: IPO Details - The IPO consists of 10,000,000 units priced at $10.00 each, with each unit including one Class A ordinary share and one-half of a redeemable warrant [1] - Each whole warrant will be exercisable 30 days after the completion of the initial business combination, allowing the holder to purchase one Class A ordinary share at $11.50 per share [1] - The units are expected to trade on Nasdaq under the ticker symbol "SCPQU" starting December 23, 2025, with separate trading for Class A ordinary shares and warrants under the symbols "SCPQ" and "SCPQW," respectively [1] Group 2: Underwriting and Closing - BTIG, LLC is acting as the sole book-running manager for the offering [2] - The underwriter has a 45-day option to purchase up to an additional 1,500,000 units at the initial public offering price to cover over-allotments [2] - The offering is expected to close on December 24, 2025, subject to customary closing conditions [2] Group 3: Company Overview - Social Commerce Partners Corporation is a special purpose acquisition company (SPAC) formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [5] - The company will primarily focus on target businesses in the social commerce (direct selling) industry [5] - The management team includes Stuart Johnson as CEO and Chairman, and Harley (Michael) Rollins as CFO, along with board members Wayne Moorehead, Peter Griscom, and Heather Chastain [5]

Core Insights - Joseph DePinto, CEO of 7-Eleven since 2005, will retire at the end of this year, marking a significant leadership change as the company prepares for an IPO in 2026 [2][3][4] - Stan Reynolds and Doug Rosencrans will serve as co-CEOs until a permanent replacement is found, with the search being a key focus for the convenience store industry leading into 2026 [3][4] - The upcoming IPO is expected to enhance 7-Eleven's growth potential by increasing flexibility and responsiveness to customer needs, leveraging its extensive network of over 9,000 stores in the U.S. [5] Company Strategy - The new CEO will be responsible for advancing transformation efforts, unlocking the full potential of 7-Eleven, and expanding its market presence in North America [4] - The IPO is anticipated to generate significant capital, enabling investments in business expansion, particularly in large-format, food-focused stores, with a goal of opening 600 new locations by 2027 [6] - The next CEO will also focus on increasing private-brand and fuel sales while reducing operating costs, which are currently higher than competitors on a per-store basis [7]

Core Viewpoint - Charles Li Xiaojia has suspended the IPO plan for Micro Connect International Finance (MCIF) due to the extended timeline outweighing anticipated benefits, impacting the company's deployment schedule and broader progress [1][2]. Group 1: IPO Suspension - The IPO application for MCIF expired on December 18 after failing to complete the listing within a six-month window [5]. - Li will now operate MCIF as a private fund and raise capital from the private sector, with Micro Connect Group committing US$100 million and seeking additional funding [5]. Group 2: Future Plans and Market Context - Li expressed strong demand for MCIF from potential limited partners and investment targets, indicating a shift to operate as a private fund for greater flexibility in fundraising and deployment [6]. - Despite the suspension, Li remains open to a potential future listing of MCIF and maintains plans to list Micro Connect Group [6]. - No company has successfully listed through HKEX's Chapter 21 regime, prompting calls for a review of this framework [6]. Group 3: Background Information - Li, who previously served as CEO of HKEX, co-founded MCIF and has been involved in various listing reforms during his tenure [3][7]. - Micro Connect has launched several projects, including the Micro Connect Macau Financial Assets Exchange in 2023, which allows institutional investors to trade daily revenue obligations [7].

Amy Butte, chief financial officer of Navan, says companies are increasingly prepared to go public, pointing to the benefits of access to capital and acquisition currency. She tells Katie Greifeld and Romaine Bostick on "The Close" that a strong year-end backdrop is supportive for capital markets. ...

As filed with the Securities and Exchange Commission on December 19, 2025 Registration No. 333-290947 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RF Acquisition Corp III (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial (I.R.S. Employer Identification Number) RF Acquisition Corp ...

Company Overview - MiniMed Group Inc. is a diabetes management firm that is set to separate from Medtronic Plc and has filed for an initial public offering (IPO) [1][4] - The company has been part of Medtronic for nearly 25 years and offers a full ecosystem of automated insulin pumps, continuous glucose monitors, and smart insulin pens [3] Financial Performance - For the six months ended October 24, MiniMed reported a net loss of $21 million on revenue of $1.5 billion, an improvement from a net loss of $23 million on revenue of $1.3 billion in the same period the previous year [2] - The company generated approximately $2.7 billion in annual revenue for fiscal year 2025, with recent double-digit percentage growth [3] IPO Details - The IPO filing positions MiniMed to potentially debut in early 2026, alongside other companies such as EquipmentShare.com Inc. and Arko Petroleum Corp. [2] - Goldman Sachs Group Inc., Bank of America Corp., Citigroup Inc., and Morgan Stanley are leading the offering, with shares expected to trade on the Nasdaq Global Select Market under the symbol MMED [5] Corporate Structure and Future Plans - Medtronic will retain at least 80.1% of the voting power post-separation, and plans to distribute shares to investors in a tax-efficient manner, potentially as a spin-off [4] - MiniMed intends to use part of the IPO proceeds to repay intercompany debt owed to Medtronic [4]

Core Insights - Joseph DePinto, CEO of 7-Eleven, will retire at the end of this year, marking a significant leadership change as the company prepares for an IPO in 2026 [4][3] - Stan Reynolds and Douglas Rosencrans will serve as co-CEOs until a permanent replacement is found, indicating a transitional phase for the company [4][6] - The new CEO will be responsible for overseeing the rollout of larger, food-focused convenience stores and enhancing technology and food offerings [5][6] Company Strategy - 7-Eleven is focusing on expanding its North American division by opening more food-centric convenience stores [4][5] - The company aims to redefine convenience and enhance customer experience across the North American market [6] - Seven & i's board is collaborating with a global executive search firm to identify DePinto's successor, emphasizing the importance of leadership in the company's transformation efforts [6][7] Leadership Transition - DePinto has led 7-Eleven for over two decades, significantly expanding the store network and driving digital and logistics transformation [7][9] - His departure comes after nearly 20 years on Seven & i's board, highlighting a long tenure of leadership and growth for the brand [7][9] - The company expresses gratitude for DePinto's contributions, indicating a positive legacy as it moves forward [6][7]

Core Viewpoint - Medtronic plc has announced the filing of a registration statement for an initial public offering (IPO) of its Diabetes business, which will operate under the name MiniMed, indicating a strategic separation from the parent company [1][2]. Company Overview - Medtronic plc is a leading global healthcare technology company headquartered in Galway, Ireland, with over 95,000 employees across more than 150 countries, focusing on innovative solutions for various health conditions [6]. - The company's mission is to alleviate pain, restore health, and extend life, with a diverse portfolio that includes cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems [6]. Diabetes Business - The Diabetes business at Medtronic aims to enhance diabetes management through advanced technology, including next-generation sensors and intelligent dosing systems, emphasizing customer experience [5]. - The separation of the Diabetes business is expected to be completed through capital markets transactions, with a preferred path being an IPO followed by a split-off [1][8]. IPO Details - MiniMed intends to list its common stock on the Nasdaq Global Select Market under the symbol MMED, although the number of shares and price range for the offering have not yet been determined [2]. - The IPO process will commence after the SEC review, subject to market conditions [2]. Underwriters - Goldman Sachs & Co. LLC, BofA Securities, Citigroup, and Morgan Stanley will serve as active bookrunners for the proposed offering, with additional support from several other financial institutions [4].

Morgan Stanley is emerging as a leading contender for a key role in SpaceX's blockbuster initial public offering, as the bank's close ties to CEO Elon Musk give it an edge in his decision, according t... ...

OpenAI may be building up to one of the largest initial public offerings ever, but CEO Sam Altman says he is not necessarily looking forward to helming a public company. “Am I excited to be a public company CEO? 0%,” Altman said in an episode of the “Big Technology Podcast” published on Thursday. “Am I excited for OpenAI to be a public company? In some ways, I am, and in some ways I think it’d be really annoying.” OpenAI is laying the groundwork for an IPO, with a Thursday report from The Wall Street Jo ...